Product Information

IBUPROFEN 600 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0426 per EA under NDC 59651036101. Its NADAC has been published 276 times since Aug 11, 2021.

FDA first approved this application on May 8, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

IBUPROFEN 600 MG TABLET

Ibuprofen
$0.0426per EA

Strength

600 mg/1

NDC

59651036101

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

IBUPROFEN

Approval Type

Generic (ANDA)

FDA Application

ANDA213794

FDA Approved

5/8/2020

TE Code

AB

On Market Since

5/8/2020

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for IBUPROFEN 600 MG TABLET has been published 276 times since Aug 11, 2021, and over the history we have for it it has declined 31.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0426 per EA
All-time high$0.0624 (Sep 15, 2021)
All-time low$0.0426 (Nov 18, 2026)
52-week high$0.0472
52-week low$0.0426
Median price$0.0525
Average price$0.0519
Largest weekly change+21.4% (Aug 21, 2024)
Weeks tracked276
Tracking sinceAug 11, 2021

Price History

1W

-7.5%

1M

-9.7%

3M

-8.5%

6M

-3.7%

1Y

-8.3%

3Y

-20.4%

5Y

-29.2%

All

-31.7%

Generic Alternatives

The matcher finds 15 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of IBUPROFEN 600 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for IBUPROFEN 600 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.0426 per EA (NDC 59651036101), effective Nov 18, 2026.

How has the price of IBUPROFEN 600 MG TABLET changed over time?

Over the history we have for it, the NADAC for IBUPROFEN 600 MG TABLET has declined 31.7%. It has been tracked across 276 weekly CMS publications since Aug 11, 2021.

What are the highest and lowest recorded NADAC prices for IBUPROFEN 600 MG TABLET?

Since Aug 11, 2021, the NADAC for IBUPROFEN 600 MG TABLET has ranged from a low of $0.0426 (Nov 18, 2026) to a high of $0.0624 (Sep 15, 2021), with a median of $0.0525 per EA.

Are there cheaper alternatives to IBUPROFEN 600 MG TABLET?

15 manufacturers publish a NADAC-priced product with the same active ingredient and strength as IBUPROFEN 600 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures IBUPROFEN 600 MG TABLET?

IBUPROFEN 600 MG TABLET (NDC 59651036101) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.